Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-20

Clinical Trial Update: The Dose Finding Study of DAOIB Added to tDCS for AD [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of DAOIB added to transcranial direct current stimulation for Alzheimer's disease is underway, sponsored by Chang Gung Memorial Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAOIB

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Transcranial Direct Current Stimulation, Dementia | Phase 2 | Status: SUSPENDED